Vol 6 (September 30, 2024): Precision Cancer Medicine

Original Article
Evaluation of the anti-tumor activity of histone deacetylase inhibitors (HDAC6) on human pancreatic adenocarcinoma (PANC-1) cell line using a zebrafish xenograft model
Mays Helmi
Precision Cancer Medicine  
2024;
6:
5  
(30 September 2024) 
PDF Full Text (197) Reporting Checklist Data Sharing Statement Peer Review File COI Form Open Access Get Permission
Case Report
Safe management of 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) + panitumumab in a patient with metastatic colorectal cancer undergoing hemodialysis for bilateral nephrectomy: a case report
Elisabetta Filoni, Vittoria Musci, Giacomo Dibisceglia, Francesco Mannavola
Precision Cancer Medicine  
2024;
6:
4  
(30 September 2024) 
PDF Full Text (303) Reporting Checklist Peer Review File COI Form Open Access Get Permission
Review Article
NTRK1/2/3: biology, detection and therapy
Maristella Bungaro, Edoardo Garbo
Precision Cancer Medicine  
2024;
6:
3  
(30 September 2024) 
PDF Full Text (154) Peer Review File COI Form Open Access Get Permission
Review Article
ALK fusions turn sixteen in lung cancer: a review on their biology, detection and therapy
Francesco Facchinetti, Laura Gandolfi, Damien Vasseur, Laura Melocchi, Seshiru Nakazawa, Marcello Tiseo, Luc Friboulet, Giulio Rossi
Precision Cancer Medicine  
2024;
6:
2  
(30 September 2024) 
PDF Full Text (175) Peer Review File COI Form Open Access Get Permission
Review Article
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions
Marco Sposito, Ilaria Mariangela Scaglione, Alessandra Dodi, Alice Avancini, Ilaria Trestini, Daniela Tregnago, Jessica Insolda, Michele Milella, Sara Pilotto, Lorenzo Belluomini
Precision Cancer Medicine  
2024;
6:
1  
(30 September 2024) 
PDF Full Text (276) Peer Review File COI Form Open Access Get Permission